Screener Summaries Updates Institutions Sign In More Updates › Earnings › XAIR Earnings · Jun 26, 2026
Beyond Air, Inc. announced its financial results for the fiscal quarter and year ended March 31, 2026, and approved a… XAIR Beyond Air, Inc.
Beyond Air, Inc. announced its financial results for the fiscal quarter and year ended March 31, 2026, and approved a change in its fiscal year-end from March 31 to December 31, effective December 31, 2026. The company will report a nine-month transition period from April 1, 2026, through December 31, 2026. Beyond Air, Inc. operates in the medical technology industry, providing respiratory solutions for patients with lung disease.
More from Beyond Air, Inc. Beyond Air preannounces preliminary Q3 revenue of $2.3 million and reaffirms full-year guidance Oct 8, 2026 Beyond Air reported $1.8 million in revenue for Q2 FY2026 with a net loss of $7.9 million, or $11.00 per share Aug 18, 2026 Beyond Air, Inc. received confirmation from Nasdaq that it has regained compliance with the minimum bid price… Aug 6, 2026 Beyond Air, Inc. entered into a securities purchase agreement on July 29, 2026, for a private placement expected to… Jul 31, 2026 Beyond Air, Inc. approved and filed a 1-for-20 reverse stock split to raise its common stock bid price above $1.00 per… Jul 9, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
